Konstruksi mutasi daerah resisten rifampin (gen rpoB) dari Mycobacterium leprae pada penderita lepra di Surabaya melalui analisis genom hasil PCR
Rifampin is a key component in the chemoterapeutic regimens used to combat both leprosy and tuberculosis. Owing to exquisite rifampin susceptibility of Mycobacterium leprae, this drug is the backbone of the multidrug therapy currently recommended by WHO for the treatment of leprosy. Resistant muta...
Main Author: | E Bimo Aksono H |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Biological Society
2012-02-01
|
Series: | Journal of Biological Researches |
Subjects: | |
Online Access: | http://berkalahayati.org/journal/f55707d4 |
Similar Items
-
Multiple rpoB Mutants of Mycobacterium tuberculosis and Second-order Selection
by: Igor Mokrousov
Published: (2004-07-01) -
Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D
by: Victoria L. Campodónico, et al.
Published: (2018-03-01) -
Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran
by: B. Motavaf, et al.
Published: (2021-05-01) -
A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis
by: Li-Yin Lai, et al.
Published: (2020-10-01) -
Molecular Identification of Mycobacterium tuberculosis and Analysis of Its Resistance to Rifampin in Sputa From Tuberculosis Suspected Patients
by: M. Syaifudin
Published: (2010-08-01)